10Nov

Lilly Moves Closer to Approval to Market Cymbalta for Chronic Pain

In CategoryDrugs and Drug Companies, Pain Management
ByRuss Bianchi

This deadly and highly addictive harmful ssri (anti depressant) is NOT a pain killer.  This pending bait and switch is more Big Pharma cross marketing FRAUD.

~ Uncle Russ

A federal panel on Thursday voted narrowly to recommend allowing Eli Lilly to market its blockbuster antidepressant Cymbalta for some chronic pain conditions like lower back ailments that affect millions of Americans.

Lilly Moves Closer to Approval to Market Cymbalta for Chronic Pain

Share

Tags: , , ,

Comments are closed.